Skip to content

Study held to see the efficacy of Barley and Kalonji Saktu(meal) along with Mefenamic acid in treating menstrual cramps

A Randomized Controlled trial to study the efficacy of Yava(Barley) and Upakunchika(Nigella sativa) Saktu as an adjuvant with Mefenamic acid in Primary Dysmenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040250
Enrollment
72
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Adarsha Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Women with moderate to severe pain intensity during menstruation 2)Menstrual cramp pain in women with age group 18 to 25 years 3)Women having regular menstrual cycle 4)Menstrual cramp pain having constitutional symptoms of diarrhoea, vomitting, nausea, fainting, headache, fatigue, sweat, anorexia and breast tenderness 5)Menstrual cramp pain occurring in 4 of the 6 menstrual cycles

Exclusion criteria

Exclusion criteria: 1)Known cases of secondary dysmenorrhea, Pelvic Inflammatory disease, PCOD, Uterine fibroid, Endometriosis, Adenomyosis, Endometrial polyp and other medical surgical conditions stimulating dysmenorrhea 2)Women who are planning to concieve

Design outcomes

Primary

MeasureTime frame
Yava(Barley) and Upakunchika(Nigella sativa) Saktu as an adjuvant with Mefenamic acid is effective in reduction of pain intensity in Primary DysmenorrheaTimepoint: 3 months study with assessment of pain severity grade and VAS score at 1st menstrual cycle, after 2nd menstrual cycle and after 3rd menstrual cycle

Secondary

MeasureTime frame
Yava(Barley)and Upakunchika(Nigella sativa)Saktu as an adjuvant with Mefenamic acid is effective in associated symptoms of Primary dysmenorrheaTimepoint: 3 months study with assessment of associated symptom grade at first menstrual cycle, after 2nd menstrual cycle and after 3rd menstrual cycle

Countries

India

Contacts

Public ContactAdarsha Patil

Dr D Y Patil College Of Ayurveda and Research Centre

drujshirke@gmail.com9850769938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026